EyePoint Pharmaceuticals Inc (EYPT)
19.74
-0.20
(-1.00%)
USD |
NASDAQ |
May 03, 16:00
19.73
-0.01
(-0.05%)
After-Hours: 20:00
EyePoint Pharmaceuticals Cash and Short Term Investments (Quarterly): 331.05M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 331.05M |
September 30, 2023 | 136.01M |
June 30, 2023 | 142.54M |
March 31, 2023 | 122.48M |
December 31, 2022 | 144.56M |
September 30, 2022 | 157.26M |
June 30, 2022 | 171.17M |
March 31, 2022 | 190.78M |
December 31, 2021 | 211.56M |
September 30, 2021 | 119.71M |
June 30, 2021 | 127.63M |
March 31, 2021 | 138.58M |
December 31, 2020 | 44.91M |
September 30, 2020 | 28.73M |
June 30, 2020 | 22.81M |
March 31, 2020 | 26.30M |
December 31, 2019 | 22.21M |
September 30, 2019 | 31.76M |
June 30, 2019 | 44.16M |
March 31, 2019 | 43.38M |
September 30, 2018 | 55.76M |
June 30, 2018 | 38.78M |
March 31, 2018 | 16.35M |
December 31, 2017 | 12.88M |
September 30, 2017 | 11.83M |
Date | Value |
---|---|
June 30, 2017 | 16.90M |
March 31, 2017 | 15.37M |
December 31, 2016 | 17.53M |
September 30, 2016 | 22.55M |
June 30, 2016 | 28.99M |
March 31, 2016 | 33.27M |
December 31, 2015 | 21.09M |
September 30, 2015 | 24.00M |
June 30, 2015 | 28.54M |
March 31, 2015 | 31.66M |
December 31, 2014 | 35.69M |
September 30, 2014 | 14.31M |
June 30, 2014 | 18.28M |
March 31, 2014 | 21.27M |
December 31, 2013 | 15.72M |
September 30, 2013 | 16.45M |
June 30, 2013 | 10.27M |
March 31, 2013 | 13.70M |
December 31, 2012 | 15.72M |
September 30, 2012 | 17.65M |
June 30, 2012 | 14.57M |
March 31, 2012 | 16.46M |
December 31, 2011 | 18.68M |
September 30, 2011 | 21.27M |
June 30, 2011 | 24.13M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
22.21M
Minimum
Dec 2019
331.05M
Maximum
Dec 2023
116.54M
Average
127.63M
Median
Jun 2021
Cash and Short Term Investments (Quarterly) Benchmarks
INVO Bioscience Inc | 0.2324M |
Bio-Path Holdings Inc | 1.052M |
Ocular Therapeutix Inc | 195.81M |
Aileron Therapeutics Inc | 17.31M |
Apellis Pharmaceuticals Inc | 351.18M |